Fundraising FoxLifespan Vision Ventures — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Immunis Biomedical develops multi-active biologics based on stem cell-derived secretomes — cell-free therapeutics containing proteins, lipids and growth factors — aimed at treating age-related and immune-related diseases.
BiotechHealthtechLongevityIrvine, US
Gabriel Nistor(Executive Officer)
BoardTakahide Koda(Director)Daniel Kraft(Director)inHans Keirstead(Chairman of the Board)
Co-investorsBold Capital PartnersJLSquadraScope Venture FundRemiges Ventures, Inc.
Remedium Bio is a biotech company developing gene therapy and biologic treatments for osteoarthritis and other rheumatology and metabolic conditions, drawing on research into cartilage regeneration and the FGF18 protein.
BiotechHealthtechLongevityBoston, US
Luppino Francesco(Executive Officer, Director)
Co-investorsUlu VenturesHKX Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.